Levothroid and Metolazone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levothroid (levothyroxine sodium) and Metolazone (metolazone). Common drug interactions include aortic stenosis among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Levothroid and Metolazone. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.

What is Metolazone?

Metolazone has active ingredients of metolazone. It is often used in swelling. eHealthMe is studying from 13,411 Metolazone users. Check the latest studies of Metolazone.



On Jul, 11, 2026

23 people who take Levothroid and Metolazone together, and have interactions are studied.

Levothroid and Metolazone drug interactions.

What are the common drug interactions of Levothroid and Metolazone, by gender? *:

female:

  1. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  2. Cellulitis (infection under the skin)
  3. Peripheral swelling
  4. Pneumonia
  5. Renal failure (kidney dysfunction)
  6. Cough
  7. Dyspnoea (difficult or laboured respiration)
  8. Medical device complication
  9. Nausea (feeling of having an urge to vomit)
  10. Presyncope

male:

  1. Dizziness
  2. Chronic kidney disease
  3. Blood potassium decreased
  4. Confusional state
  5. Diarrhoea
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dyspnoea (difficult or laboured respiration)
  8. Electrocardiogram st segment depression
  9. Electrocardiogram t wave inversion
  10. Flatulence (flatus expelled through the anus)

What are the common drug interactions of Levothroid and Metolazone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Cough
  5. Fatigue (feeling of tiredness)
  6. Gait disturbance

60+:

  1. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  2. Cellulitis (infection under the skin)
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Medical device complication
  6. Presyncope
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Abdominal pain lower
  9. Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
  10. Blood albumin decreased

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 30.43%
  2. Multiple Myeloma (cancer of the plasma cells): 4 people, 17.39%
  3. Pain: 3 people, 13.04%
  4. High Blood Pressure: 3 people, 13.04%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.04%
  6. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 8.70%
  7. Nausea (feeling of having an urge to vomit): 2 people, 8.70%
  8. Muscle Spasms (muscle contraction): 2 people, 8.70%
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 8.70%
  10. Gastric Ph Decreased: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and Metolazone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levothroid and Metolazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Metolazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metolazone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and metolazone (the active ingredients of Levothroid and Metolazone, respectively), and Levothroid and Metolazone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: